Cooley LLP announced today that it advised Versartis, Inc. on its $144.9 million initial public offering. Versartis, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders, now trades on the NASDAQ Global Stock Market under the symbol “VSAR.” (more…)
Tags
Carlsbad Cerritos Costa Mesa Dallas Irvine Jakarta Lake Tahoe London Los Angeles Menlo Park Mountain View Napa Valley Newport Beach Oakland Ontario Orange County Palo Alto Pasadena Redwood Shores Riverside Sacramento San Diego San Francisco San Jose Santa Monica Silicon Valley St. Helena Sunnyvale Thousand Oaks Ventura Walnut Creek
WP Cumulus Flash tag cloud by Roy Tanck requires Flash Player 9 or better.